Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Dissecting the code for regulatory T cell entry into the tissues and differentiation into tissue-resident cells

Objective

Foxp3+ regulatory T cells (Tregs) are highly potent immunosuppressive cells. Most of our understanding of Tregs is based on the population present in lymphoid tissues, however to harness their anti-inflammatory power in the clinic we need to understand the tissue-resident population. Converting generic Tregs into expanded proto-tissue Tregs, capable of entering inflamed tissues, adapting to local conditions, and driving an anti-inflammatory pro-rejuvenation process would transform cell therapy. However to be able to encode a tissue-resident function into Tregs, we first need to decode the cellular induction signals that allow a Treg to become a tissue Treg, and decode the molecular processes of Treg tissue entry and reprogramming into the residential phenotype.

This project seeks to dissect Treg tissue-residency at an unprecedented scale. The applicant’s team has developed and validated cutting-edge technology, “FlowCodes”, to enable massively-parallel functional testing of the tissue Treg repertoire and genetic control. The project will test the cellular behaviour of ~500 tissue Treg TCRs and ~500 gut Treg TCRs through retrogenic TCR analysis, across multiple organs, in health and disease, identifying the site of Treg induction and disease-responsiveness for each. The project will further test ~400 potential genetic cofactors (migration genes, transcription factors, metabolic adaptors), for contribution to tissue residency and potential to aid anti-inflammatory responses. Finally, the project will provide a proof-of-concept for re-encoding the identified residency features, and systematically test combinations of decoded TCR and genetic factors for the ability to augment tissue-residency and disease suppression in Tregs. The project therefore not only unravels the biological rules for Treg residency, it provides a pathway back to Treg cell therapy engineering.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-ADG

See all projects funded under this call

Host institution

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Net EU contribution
€ 2 499 960,00
Address
TRINITY LANE THE OLD SCHOOLS
CB2 1TN CAMBRIDGE
United Kingdom
Region
East of England East Anglia Cambridgeshire CC
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)